Jacob Lalezari REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JACOB LALEZARI, Quest Clinical Research, San Francisco Maraviroc could be a
Jacob Lalezari
REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007JACOB LALEZARI, Quest Clinical Research, San FranciscoMaraviroc could be a useful new drug for the treatment of some HIV infections, according toJacob Lalezariof Quest Clinical Research in San Francisco. He presented 48 week results from the MOTIVATE 1 study and Derek Thorne spoke to him at ICAAC in Chicago.